Moderna Gets $50 Million to Rush Ebola mRNA Vaccine

With a Bundibugyo Ebola outbreak actively raging and no approved treatments for this specific strain, officials have fast-tracked $50 million to Moderna to develop an mRNA vaccine. The funding signals a deliberate bet on the same platform that delivered COVID-19 vaccines at record speed.